Cargando…
Progression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages
Glioblastoma (GBM) is the most aggressive type of brain tumor. In this context, animal models represent excellent tools for the early detection and longitudinal mapping of neuronal dysfunction, that are critical in the preclinical validation of new therapeutic strategies. In a mouse glioma model, we...
Autores principales: | Vannini, Eleonora, Maltese, Federica, Olimpico, Francesco, Fabbri, Alessia, Costa, Mario, Caleo, Matteo, Baroncelli, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410325/ https://www.ncbi.nlm.nih.gov/pubmed/28212563 http://dx.doi.org/10.18632/oncotarget.15328 |
Ejemplares similares
-
CTX-CNF1 Recombinant Protein Selectively Targets Glioma Cells In Vivo
por: Vannini, Eleonora, et al.
Publicado: (2021) -
The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model
por: Vannini, Eleonora, et al.
Publicado: (2014) -
Bacterial Toxins and Targeted Brain Therapy: New Insights from Cytotoxic Necrotizing Factor 1 (CNF1)
por: Tantillo, Elena, et al.
Publicado: (2018) -
Voluntary Physical Exercise Reduces Motor Dysfunction and Hampers Tumor Cell Proliferation in a Mouse Model of Glioma
por: Tantillo, Elena, et al.
Publicado: (2020) -
The bacterial toxin CNF1 as a tool to induce retinal degeneration reminiscent of retinitis pigmentosa
por: Guadagni, Viviana, et al.
Publicado: (2016)